EU uses ‘rolling reviews’ to speed up approval of AstraZeneca’s vaccine candidate
Real-time reviews of potential shots are under way as the FDA widens its probe into an adverse reaction
01 October 2020 - 20:37
Bengaluru — The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential Covid-19 vaccine as it emerges, the first of such moves aimed at speeding up any approval process in the region for a vaccine.
The European Medicines Agency (EMA) said on Thursday its human medicines committee is evaluating the first batch of non-clinical data on the vaccine from laboratory studies, and will continue to do so until sufficient data is available for a final decision...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.